India gentamycin market is expected to grow at a formidable rate during the forecast period. The India gentamycin market is driven by the growing prevalence of animal diseases outbreaks. Gentamycin finds maximum usage in veterinary medicine. Additionally, gentamycin is used in the treatment of several human diseases and infections including urinary tract infections, renal disorders, sepsis, among others. This in turn is expected to positively influence the market growth during the forecast period. Besides, the high efficacy and affordability of the medication are further expected to fuel the market growth through FY2026.
The India gentamycin market is segmented based on source, form, route of administration, distribution channel, application, company and region. Based on route of administration, the market can be categorized into eye drops, tablet, capsule, syrup, injection, cream, gel, ointment and others. The intravenous route is expected to witness significant growth in the market through FY2026 since a large dose of drug can be administered using this route of drug administration. Also, this is the most effective route of administration for the drugs that are not orally absorbed with 100% bioavailability.
The major players operating in the India gentamycin market are Taj Pharmaceuticals Ltd., Bayer India Ltd., Zydus Cadila Healthcare Ltd., Neon Laboratories Ltd., Hetero Healthcare Ltd., Gracure Pharmaceuticals Ltd., Intas Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Fresenius Kabi India Pvt. Ltd., Nestor Pharmaceuticals Ltd. and others. Major companies are developing advanced technologies, receiving approvals from regulatory bodies and launching new products in order to stay competitive in the market. Other competitive strategies include mergers & acquisitions and new product developments.
Years considered for this report
Historical YearsFY2016-FY2019
Base YearFY2020
Estimated YearFY2021
Forecast PeriodFY2022–FY2026
Objective of the Study
- To analyze and estimate the market size of India gentamycin market from FY2016 to FY2019.
- To estimate and forecast the market size of India gentamycin market from FY2020 to FY2026 and growth rate until FY2026.
- To classify and forecast India gentamycin market based on source, form, route of administration, distribution channel, application, company and regional distribution.
- To identify dominant region or segment in the India gentamycin market.
- To identify drivers and challenges for India gentamycin market.
- To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India gentamycin market.
- To identify and analyze the profile of leading players operating in India gentamycin market.
- To identify key sustainable strategies adopted by market players in India gentamycin market.
Click here to download the sample
TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.
TechSci Research calculated the market size of
Key Target Audience
- Gentamycin manufacturers/ suppliers/ distributors
- Market research and consulting firms
- Government bodies such as regulating authorities and policy makers
- Organizations, forums and alliances related to gentamycin
The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers and partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.
